Omarigliptin and its Impurities
Omarigliptin used for once-weekly treatment of type 2 diabetes and currently under development by Merck & Co.Reference standards of Omarigliptin API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

 
	
			                                   
																				 
																				 
 
 
 
